OREN BITTON

About OREN BITTON

Oren Bitton currently holds a key executive position at BIOSYNEX, the French rapid-diagnostic company, where he was promoted to Group Deputy Managing Director in May 2024. He joined BIOSYNEX in 2011 and has developed his career internally through successive responsibilities in sales, commercial development, and business-unit leadership. Prior to his current role, he led the Pharma Business Unit from September 2022, overseeing business growth and managing the company’s post-Covid transition. Before that, he also served in commercial leadership roles, including OTC business responsibilities, which gave him a strong understanding of distribution channels, market dynamics in healthcare, and the operational levers that support profitability. His promotion was part of a broader governance reinforcement at BIOSYNEX, alongside founder and Chairman-CEO Larry Abensur and the company’s other senior leaders. In his current role, Bitton contributes to delivering the growth and profitability objectives of the company’s TRANSFORM 2025 strategic plan. His trajectory reflects a steady rise through the organization, built on a combination of commercial expertise and operational execution. He is a graduate of HEC Paris, where he completed an Executive Master of Sciences in general management, adding an academic foundation to his hands-on experience in a listed healthcare diagnostics group. His profile is especially relevant in a sector where speed of execution, supply-chain resilience, regulatory awareness, and market access are critical. Overall, Oren Bitton stands out as one of BIOSYNEX’s core executives, with a central role in the group’s transformation, governance, and strategic delivery.